Thymidine Kinase: A Potential Drug Target for Cancer and Cellular Aging

Target Name: Thymidine Kinase

NCBI ID: P14319

Thymidine Kinase

Other Name(s): Thymidine Kinase

Thymidine Kinase: A Potential Drug Target for Cancer and Cellular Aging

Thymidine kinase (TK) is an enzyme that plays a crucial role in the regulation of DNA replication and repair in eukaryotic cells. The nonspecific subtype of TK, also known as TK-CS, is a protein that is expressed in various cell types and is involved in the process of DNA replication.

TK is composed of two subunits, TK1 and TK2, which are responsible for the two distinct functions of the enzyme. TK1 functions as the primary kinase, activating thymidine monophosphate (TMP) to thymidine triphosphate (TTP), which is then converted to form DNA replication initiation complex (DIC). TK2, on the other hand, functions as a protein that can interact with TK1 and enhance its catalytic activity.

The role of TK in DNA replication is essential for the growth and development of eukaryotic organisms. During DNA replication, TK1 activates TMP to TTP, which then forms DIC, a complex that is responsible for initiation of the DNA replication process. TK2, through its interaction with TK1, can enhance the catalytic activity of TK1, leading to an increase in the rate of DNA replication.

In addition to its role in DNA replication, TK has also been shown to play a role in the regulation of apoptosis (programmed cell death). TK has been shown to be involved in the regulation of apoptosis by promoting the formation of DNA double-strand breaks, which can lead to the formation of an apoptosis-sensitive complex.

The nonspecific subtype of TK has been identified as a potential drug target in the field of cancer. Studies have shown that TK is overexpressed or mutated in various types of cancer, including breast, ovarian, and colorectal cancer. Overexpression of TK has been shown to increase the sensitivity of cancer cells to chemotherapy and radiation, while mutations in TK have been associated with the development of resistance to drugs.

Furthermore, TK has also been shown to play a role in the regulation of cellular aging. TK-CS has been shown to be involved in the regulation of cellular senescence, which is the process by which cells become resistant to environmental stressors and eventually die.

In conclusion, thymidine kinase (TK) is an enzyme that plays a crucial role in the regulation of DNA replication and repair in eukaryotic cells. The nonspecific subtype of TK, also known as TK-CS, is a protein that is involved in the process of DNA replication and has also been shown to play a role in the regulation of apoptosis and cellular aging. As a result, TK is a potential drug target in the field of cancer and cellular aging.

Protein Name: Thymidine Kinase (nonspecified Subtype)

The "Thymidine Kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Thymidine Kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets